Browse studies

Find your next paid study

27,375 recruiting studies available now

A Phase 2, Multicenter, Double-Blind, Randomized, Controlled Trial of the Safety and Immunogenicity of a Self-Amplifying mRNA COVID-19 Vaccine in Adult Hematopoietic Cell Transplant Recipients

This phase IIb trial compares the effect of LUNAR-COV19 vaccine to Comirnaty vaccine in treating adult patients who have received a hematopoietic cell transpla…

Hematopoietic and Lymphatic System Neoplasm

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Fred Hutchinson Cancer CenterNCT07390968

Phase 1

An Open-label, Pharmacokinetic and Safety Trial Optimizing PreTerm Infant Ampicillin Dosing

The goal of this clinical trial is to learn if preterm infants who are prescribed antibiotics shortly after birth can safely receive a shorter course of antibi…

Early Onset SepsisPreterm NeonatesNICU+2 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Duke UniversityNCT07610486

LXR as a Novel Therapeutic Target in DR

Results from large clinical trials demonstrate a strong association between lipid abnormalities and progression of the most common microvascular complication, …

Diabetic Retinopathy

Estimated

Pay not disclosed — ask the coordinator

University of Alabama at BirminghamNCT03403686

Phase 1

A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation

This research study is studying cytokine induced memory-like natural killer (CIML NK) cells combined with IL-2 in adult patients (18 years of age or older) wit…

Acute Myeloid LeukemiaMyelodysplastic SyndromesMyeloproliferative Neoplasm+1 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Dana-Farber Cancer InstituteNCT04024761

Observational

Supporting Practices In Respecting Elders Phase 2

This study consists of three aims focused on examining the feasibility of adding the Geriatric Resources and Assessment for the Care of Elders (GRACE) model to…

AgingPreventive CareMultimorbidity+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Massachusetts General HospitalNCT07166861

Phase 3

A Multi-center, Open-label, Single-arm Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

This is a multinational, open label, single arm study that will evaluate the impact of early multi-immune modulation with rilzabrutinib in adult ITP patients w…

Immune Thrombocytopenia

Estimated

~$50 – $2,250

Actual pay is set by the research site.

SanofiNCT07007962

Phase 2

A New Intervention to Improve Function in Veterans With Anxiety and Depression

Anxiety and depression symptoms occur at high rates in Veteran populations and can significantly impact function, compromising the ability to work and to succe…

Anxiety and Depression

Estimated

~$75 – $1,800

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT06188923

Phase 2

Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery

The goal of this prospective pragmatic randomized clinical trial is to determine if preoperative administration of tranexamic acid (TXA) reduces bleeding durin…

BleedingColorectal DisordersThromboembolism+1 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Kristen BanNCT06657924

Phase 1

Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)

To find the highest tolerable dose and recommended dose of PRAME-TCR-NK cells that can be given to participants with recurrent and/or refractory melanoma. The …

Phase 1Recurrent MelanomaRefractory Melanoma

Estimated

~$150 – $3,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT06660420

Phase 1

IIT2021-12-Reckamp-Osi105: Phase I Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer

The purpose of this study is to examine the combination of osimertinib and carotuximab to assess the safety and find the recommended dose for treatment of adva…

Non Small Cell Lung CancerLung Cancer

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Karen Reckamp, MD, MSNCT05401110

Phase 2

A Phase 2 Trial of Leflunomide, Pomalidomide, and Dexamethasone for Relapsed/Refractory Multiple Myeloma

This phase II trial studies how well leflunomide, pomalidomide, and dexamethasone work for the treatment of multiple myeloma that has come back (relapsed) or d…

Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

City of Hope Medical CenterNCT04508790

Observational

Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge

This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfa…

Type 2 Diabetes Mellitus (T2DM)Type 1 Diabetes Mellitus (T1DM)Hyperglycemia

Estimated

~$10 – $750

Actual pay is set by the research site.

Vanderbilt University Medical CenterNCT06852950